Abstract:Background: The etiopathogenesis of hepatic stellate cells (HSC) activation has yet to be completely comprehended, and there has been broad concern about the interplay between amino acid transporter and cell proliferation. This study proposed exploring the molecular mechanism from amino acid transport-related genes in HSC activation by bioinformatic methods, seeking to identify the potentially crucial biomarkers. Methods: GSE68000, the mRNA expression profile dataset of activated HSC, was applied as the training dataset, and GSE67664 as the validation dataset. Differently expressed amino acid transport-related genes (DEAATGs), GO, DO, and KEGG analyses were utilized. We applied the protein-protein interaction analysis and machine learning of LASSO and random forests to identify the target genes. Moreover, single-gene GESA was executed to investigate the potential functions of target genes via the KEGG pathway terms. Then, a ceRNA network and a drug-gene interaction network were constructed. Ultimately, correlation analysis was explored between target genes and collagen alpha I (COL1A), alpha-smooth muscle actin (α-SMA), and immune checkpoints. Results: We identified 15 DEAATGs, whose enrichment analyses indicated that they were primarily enriched in the transport and metabolic process of amino acids. Moreover, two target genes (SLC7A5 and SLC1A5) were recognized from the PPI network and machine learning, confirmed through the validation dataset. Then single-gene GESA analysis revealed that SLC7A5 and SLC1A5 had a significant positive correlation to ECM−receptor interaction, cell cycle, and TGF−β signaling pathway and negative association with retinol metabolism conversely. Furthermore, the mRNA expression of target genes was closely correlated with the COL1A and α-SMA, as well as immune checkpoints. Additionally, 12 potential therapeutic drugs were in the drug-gene interaction network, and the ceRNA network was constructed and visualized. Conclusion: SLC7A5 and SLC1A5, with their relevant molecules, could be potentially vital biomarkers for the activation of HSC.

Characterization and Sub-cellular Localization of GalNAc-Binding Proteins Isolated from Human Hepatic Stellate Cells.

Alteration and Localization of Glycan‐binding Proteins in Human Hepatic Stellate Cells During Liver Fibrosis

Alteration of N-glycoproteins/N-glycosites in Human Hepatic Stellate Cells Activated with Transforming Growth Factor-Β1.

Alteration of Protein Glycosylation in Human Hepatic Stellate Cells Activated with Transforming Growth Factor-Β1.

Identification and Localization of Xylose-Binding Proteins As Potential Biomarkers for Liver Fibrosis/cirrhosis.

Biglycan promotes hepatic fibrosis through activating heat shock protein 47

Profiling of Concanavalin A-binding Glycoproteins in Human Hepatic Stellate Cells Activated with Transforming Growth Factor-Β1.

Expression of Fc Fragment Receptors of Immunoglobulin G (fcγrs) in Rat Hepatic Stellate Cells

Glial Cell Line-Derived Neurotrophic Factor (GDNF) Mediates Hepatic Stellate Cell Activation Via ALK5/Smad Signalling

Upregulation of GLT25D1 in Hepatic Stellate Cells Promotes Liver Fibrosis Via the TGF-β1/SMAD3 Pathway in Vivo and in Vitro

CUG-binding Protein 1 Regulates HSC Activation and Liver Fibrogenesis

Galanin Receptor 2 Mediates Antifibrogenic Effects of Galanin on Hepatic Stellate Cells

Nogo‐B: A Potential Indicator for Hepatic Cirrhosis and Regulator in Hepatic Stellate Cell Activation

[Function of TTG1A in Hepatic Stellate Cells].

Newly expressed galanin type 2 receptor suppresses proliferation of activated hepatic stellate cells

Unraveling the Activation Process and Core Driver Genes of HSCs During Cirrhosis by Single-Cell Transcriptome.

Identification of potential biomarkers from amino acid transporter in the activation of hepatic stellate cells via bioinformatics

Gene expression profiles during activation of cultured rat hepatic stellate cells by tumoral hepatocytes and fetal bovine serum

The inhibiting effect of galanin on activation state of hepatic stellate cells mediated through type 2 galanin receptor

Divergence of TGFβ Signaling in Activated Hepatic Stellate Cells Downstream from Smad2 Phosphorylation

Involvement of the Nuclear High Mobility Group B1 Peptides Released from Injured Hepatocytes in Murine Hepatic Fibrogenesis.